Velcade . Blood-Cancer Drug Hits $1 Billion .

Year-to-date sales of blood-cancer drug Velcade hit $1 billion in November, indicating the medicine's sales grew more than 25% in a year that saw broadened approval from the Food and Drug Administration ...